Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AC127070.1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | AC129492.1 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | AC240274.1 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.009 |
mRNA | ACAA1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
mRNA | ACACA | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
mRNA | ACAP1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.008 |
mRNA | ACAP2 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | ACAT1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
mRNA | ACER2 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
mRNA | ACOT11 | CTRPv2 | pan-cancer | AAC | 0.17 | 8e-06 |